PEB 📈 Pebblebrook Hotel Trust - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US70509V1008
PEB: Hotels, Resorts, Guest Rooms
Pebblebrook Hotel Trust, listed on the New York Stock Exchange under the ticker symbol PEB, operates as a real estate investment trust, or REIT, focusing primarily on the ownership of lifestyle hotels and resorts. This strategic focus allows the company to capitalize on the growing demand for unique, experience-driven accommodations in both urban and resort settings. By concentrating on these specific markets, Pebblebrook Hotel Trust has established itself as a significant player in the hospitality sector, particularly in the United States.
The company's portfolio is substantial, comprising 46 hotels and resorts that collectively offer approximately 12,000 guest rooms. This diverse range of properties is strategically distributed across 13 key urban and resort markets, enabling Pebblebrook to cater to a broad spectrum of travelers, from those seeking vibrant city experiences to those looking for relaxing getaway destinations. The scale and scope of its operations position Pebblebrook Hotel Trust as the largest owner of urban and resort lifestyle hotels and resorts in the United States, underscoring its commitment to providing high-quality accommodations and exceptional guest experiences.
From an investment perspective, Pebblebrook Hotel Trust is categorized as a common stock, with the International Securities Identification Number (ISIN) US70509V1008. It falls under the GICS Sub Industry classification of Hotel & Resort REITs, which includes companies engaged in the ownership and operation of hotels, motels, and resorts. For investors seeking exposure to the hospitality sector, particularly those interested in the unique opportunities presented by lifestyle hotels and resorts, Pebblebrook Hotel Trust represents an intriguing option. Additional information about the company, including its portfolio, mission, and investor relations, can be found on its official website, https://www.pebblebrookhotels.com.
Additional Sources for PEB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PEB Stock Overview
Market Cap in USD | 1,625m |
Sector | Real Estate |
Industry | REIT - Hotel & Motel |
GiC Sub-Industry | Hotel & Resort REITs |
IPO / Inception | 2009-12-09 |
PEB Stock Ratings
Growth 5y | -55.4% |
Fundamental | -10.9% |
Dividend | 32.4% |
Rel. Strength Industry | -413 |
Analysts | 3.23/5 |
Fair Price Momentum | 12.38 USD |
Fair Price DCF | 20.84 USD |
PEB Dividends
Dividend Yield 12m | 0.30% |
Yield on Cost 5y | 0.16% |
Annual Growth 5y | 0.00% |
Payout Consistency | 91.4% |
PEB Growth Ratios
Growth Correlation 3m | 61.6% |
Growth Correlation 12m | -73.8% |
Growth Correlation 5y | -29% |
CAGR 5y | -12.07% |
CAGR/Mean DD 5y | -0.35 |
Sharpe Ratio 12m | -0.41 |
Alpha | -49.53 |
Beta | 1.60 |
Volatility | 36.93% |
Current Volume | 1519.7k |
Average Volume 20d | 1528.5k |
As of January 15, 2025, the stock is trading at USD 13.36 with a total of 1,519,736 shares traded.
Over the past week, the price has changed by -1.49%, over one month by -8.49%, over three months by +4.99% and over the past year by -14.16%.
Neither. Based on ValueRay Fundamental Analyses, Pebblebrook Hotel Trust is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.90 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PEB as of January 2025 is 12.38. This means that PEB is currently overvalued and has a potential downside of -7.34%.
Pebblebrook Hotel Trust has received a consensus analysts rating of 3.23. Therefor, it is recommend to hold PEB.
- Strong Buy: 3
- Buy: 0
- Hold: 8
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, PEB Pebblebrook Hotel Trust will be worth about 13.4 in January 2026. The stock is currently trading at 13.36. This means that the stock has a potential upside of +0.07%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 15.4 | 14.9% |
Analysts Target Price | 16 | 20.1% |
ValueRay Target Price | 13.4 | 0.1% |